COMMUNIQUÉS West-GlobeNewswire

The Aesthetic Show Celebrates 19 Years of Innovation, Education, and Excellence in Aesthetic Medicine — Announces Expanded 2026 Event in Las Vegas, June 25 - 28
28/04/2026
LAS VEGAS, April 28, 2026 (GLOBE NEWSWIRE) -- The Aesthetic Show (TAS), one of the most respected and dynamic events in aesthetic medicine, proudly announces its 19th annual gathering this June 25th - 28th, marking [...]
MiniMed announces Health Canada License for Simplera Sync™ Sensor, Type 2 Diabetes Indication with MiniMed™ 780G System
28/04/2026
Latest authorization expands MiniMed CGM portfolio in Canada BRAMPTON, Ontario, April 28, 2026 (GLOBE NEWSWIRE) -- MiniMed Group, Inc. (MiniMed; Nasdaq: MMED), a global leader in insulin delivery, announced Health [...]
Alira Health Joins PFMD Effort to Advance Patient-Centered Evidence Generation
28/04/2026
Contribution will support multi-stakeholder efforts to strengthen the use of patient experience data in healthcare decision-making FRAMINGHAM, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- Alira Health today announced its [...]
Clariane annonce le succès de son offre de 230 millions d’euros d’obligations senior additionnelles
28/04/2026
NE PAS DIFFUSER, PUBLIER OU DISTRIBUER, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE, AU CANADA, AU JAPON OU EN AUSTRALIE, OU DANS TOUTE AUTRE JURIDICTION OU IL EST ILLÉGAL DE DIFFUSER, DE PUBLIER OU DE [...]
BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night
28/04/2026
LAS VEGAS, April 28, 2026 (GLOBE NEWSWIRE) -- via IBN — BioAdaptives, Inc. (OTC: BDPT) today announced the official launch of MyndSystem™ and website. MyndSystem™ was originally developed for professional fighters. We [...]
Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia
28/04/2026
Publication reports statistically significant improvement in sleep quality following treatment with Nexalin’s 15 mA, 77.5 Hz stimulation approach, with no meaningful improvement in the sham group Neuroimaging data [...]
Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy
28/04/2026
- Orphan drug designation from the European Commission underscores Solid’s commitment to advance SGT-003 through a global development effort for individuals living with Duchenne muscular dystrophy - CHARLESTOWN, Mass., [...]
Aveanna to Participate at the Barclays 30th Annual Leveraged Finance Conference
28/04/2026
ATLANTA, April 28, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Barclays 30 th Annual Leveraged Finance Conference in [...]
Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel
28/04/2026
Agreement facilitates flexible, scalable automated industrialized production of rese-cel for many thousands of patients per year at a cost per batch that is among the lowest in the industry Initial translational data [...]
Playground Pediatrics Expands Pediatric Access Across Four States
28/04/2026
High-quality pediatric care is growing in Georgia, North Carolina, Pennsylvania, and Tennessee NASHVILLE, Tenn., April 28, 2026 (GLOBE NEWSWIRE) -- Playground Pediatrics, a physician-led pediatric primary care services [...]
Plus Therapeutics Secures Blue Shield of California Coverage for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
28/04/2026
Expands access by 6 million covered lives, advancing commercial momentum for CNSide® in metastatic CNS cancers HOUSTON, April 28, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus [...]
Biomolecular Holdings Announces Issuance of Foundational Patents for Revolutionary Tetrahedral Antibody Technology
28/04/2026
BURLINGAME, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Biomolecular Holdings LLC, a privately-held biotechnology company advancing next-generation antibody architectures, today announced that the United States Patent [...]
Silexion Therapeutics Announces Successful Submission of Phase 2/3 Clinical Trial Application to Germany’s BfArM for SIL204 in KRAS-Driven Locally Advanced Pancreatic Cancer
28/04/2026
CTA submission positions Silexion for European Phase 2/3 trial of SIL204 in KRAS-driven pancreatic cancer, with Germany serving as Reference Member State for the EU program Grand Cayman, Cayman Islands, April 28, 2026 ( [...]
Cynet Launches New Capabilities for CyAI Engine That Improves Itself Over Time
28/04/2026
New AI capabilities create a feedback loop where analyst input and automated analysis continuously improve threat detection and response BOSTON, April 28, 2026 (GLOBE NEWSWIRE) -- Cynet, the unified, AI-powered [...]
Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution
28/04/2026
– ARCALYST ® (rilonacept) Q1 2026 net product revenue of $214.3 million, representing 56% year-over-year growth – – ARCALYST 2026 expected net product revenue increased to $930 - $945 million – – KPL-387 Phase 2 [...]
Nautilus Biotechnology Reports First Quarter 2026 Financial Results
28/04/2026
SEATTLE, April 28, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the first quarter ended [...]
BioCardia Announces Allowance of Japanese Patent on Proprietary Heart3D™ Fusion Imaging Software for Procedure Planning and Realtime Navigation During CardiAMP Cell Therapy Procedures
28/04/2026
SUNNYVALE, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today [...]
InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement
28/04/2026
JENA, Germany, April 28, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system (the “Company”), today announced [...]
Ritedose Reaches “1,000 Hours of Purpose”
28/04/2026
Employee-led initiative deepens Ritedose's commitment to Midlands nonprofits and the communities they serve COLUMBIA, S.C., April 28, 2026 (GLOBE NEWSWIRE) -- The Ritedose Corporation today announced a significant [...]

Pages